UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 9
September-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2409259


Registration ID:
546938

Page Number

c533-c542

Share This Article


Jetir RMS

Title

DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR THE ESTIMATION OF ACALABRUTINIB IN TABLET DOSAGE FORM

Abstract

The estimate of acalabrutinib in pharmaceutical tablet dosage form was accomplished through the development and validation of a unique, accurate, exact, sensitive, and appropriate High Performance Thin Layer Chromatography (HPTLC) method. The chromatographic separation of acalabrutinib was accomplished on a Silica gel 60 F254 HPTLC plate as the stationary phase. The mobile phase consisted of a 75: 15: 5: 1% v/v/v/v mixture of toluene, ethanol, ethyl acetate, and glacial acetic acid (GAA). At 230 nanometres, acalabrutinib was detected and quantified. It was discovered that the system produced a sharp peak and a well-resolved discrete band at an appropriate Rf value of 0.26. The suggested method's performance was verified in accordance with ICH requirements for robustness, linearity, accuracy, precision, LOD, and LOQ. A correlation coefficient of 0.9998 was discovered to indicate the linearity of the molecule within the 10-80ng/band range. It was discovered that the limits of detection and quantification were, respectively, 0.004 µg/ml and 0.14 ng/band. Since there was no prior HPTLC method for estimating acalabrutinib in pharmaceutical tablet dose form, the current method was innovative. It was also effectively employed for regular analysis and quality checks of the drug.

Key Words

Cite This Article

"DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR THE ESTIMATION OF ACALABRUTINIB IN TABLET DOSAGE FORM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 9, page no.c533-c542, September-2024, Available :http://www.jetir.org/papers/JETIR2409259.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR THE ESTIMATION OF ACALABRUTINIB IN TABLET DOSAGE FORM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 9, page no. ppc533-c542, September-2024, Available at : http://www.jetir.org/papers/JETIR2409259.pdf

Publication Details

Published Paper ID: JETIR2409259
Registration ID: 546938
Published In: Volume 11 | Issue 9 | Year September-2024
DOI (Digital Object Identifier):
Page No: c533-c542
Country: Navi mumbai, maharshtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000236

Print This Page

Current Call For Paper

Jetir RMS